Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Federal Trade Commission
Fuji
US Department of Justice
Argus Health
Teva
McKesson
Chinese Patent Office
Boehringer Ingelheim

Generated: May 22, 2018

DrugPatentWatch Database Preview

DORZOLAMIDE HYDROCHLORIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Dorzolamide Hydrochloride patents expire, and what generic alternatives are available?

Dorzolamide Hydrochloride is a drug marketed by Apotex Inc, Bausch And Lomb, Hi Tech Pharma, Luitpold, Sandoz Inc, Teva Pharms, Watson Labs Inc, Zambon Spa, Akorn Inc, Lannett Co Inc, and Sandoz. and is included in nineteen NDAs.

The generic ingredient in DORZOLAMIDE HYDROCHLORIDE is dorzolamide hydrochloride; timolol maleate. There are fourteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the dorzolamide hydrochloride; timolol maleate profile page.
Drug patent expirations by year for DORZOLAMIDE HYDROCHLORIDE
Pharmacology for DORZOLAMIDE HYDROCHLORIDE
Synonyms for DORZOLAMIDE HYDROCHLORIDE
(4S,6S)-4-(Ethylamino)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide 7,7-dioxide, monohydrochloride
(4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride
(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide hydrochloride
(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide;hydrochloride
130693-82-2
279D961
4H-Thieno(2,3-b)thiopyran-2-sulfonamide, 4-(ethylamino)-5,6-dihydro-6-methyl-, 7,7-dioxide, monohydrochloride, (4S-trans)-
4H-Thieno(2,3-b)thiopyran-2-sulfonamide, 5,6-dihydro-4-(ethylamino)-6-methyl-, 7,7-dioxide, monohydrochloride, (4S,6S)-
ABP001060
AC-5244
AC1OCF25
AK323617
AKOS005146235
AKOS015895951
API0007146
BC208520
Bio-0123
C10H16N2O4S3.HCl
CAS-130693-82-2
CC-27373
CCG-221116
CHEBI:4703
CHEMBL1201162
Cosopt
CS-1858
CTK8E7974
D00653
D4189
Dorzolamide (hydrochloride)
Dorzolamide for system suitability, European Pharmacopoeia (EP) Reference Standard
Dorzolamide HCl
Dorzolamide HCl salt
Dorzolamide hydrochloride (JP17/USP)
Dorzolamide hydrochloride [USAN:USP]
Dorzolamide hydrochloride, European Pharmacopoeia (EP) Reference Standard
Dorzolamide hydrochloride, United States Pharmacopeia (USP) Reference Standard
Dorzolomide hydrochloride
DSSTox_CID_25530
DSSTox_GSID_45530
DSSTox_RID_80933
DTXSID1045530
FT-0082547
FT-0631133
HMS1571O14
HY-B0109A
I06-1271
J10249
K-4065
KB-50425
KS-00000XJI
KS-1348
L 671152
L-671,152
L-671152
MK 0507
MK-0507
MK-507
MLS002154162
MolPort-005-935-141
NCGC00016977-01
NCGC00179244-03
OSRUSFPMRGDLAG-QMGYSKNISA-N
QZO5366EW7
RTC-070963
s1375
SC-18010
SCHEMBL41152
SMR001233461
TC-070963
Tox21_110720
Tox21_110720_1
Trusopt
UNII-QZO5366EW7

US Patents and Regulatory Information for DORZOLAMIDE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc DORZOLAMIDE HYDROCHLORIDE dorzolamide hydrochloride SOLUTION/DROPS;OPHTHALMIC 078395-001 Oct 28, 2008 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs Inc DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 202054-001 Sep 3, 2014 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms DORZOLAMIDE HYDROCHLORIDE dorzolamide hydrochloride SOLUTION/DROPS;OPHTHALMIC 078756-001 Dec 4, 2008 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Luitpold DORZOLAMIDE HYDROCHLORIDE dorzolamide hydrochloride SOLUTION/DROPS;OPHTHALMIC 079186-001 Nov 18, 2009 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Dow
Cipla
Merck
Julphar
Harvard Business School
Queensland Health
Federal Trade Commission
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.